Balcinrenone, a Nonsteroidal Mineralocorticoid Receptor Antagonist, Attenuates Renal Fibrosis Through Modulation of TGF-β-Smad Signaling
Journal of the American Society of Nephrology · 2026-10 · 37 (10S)
DOI: 10.1681/asn.2026757drstb ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Society of Nephrology, 2026-10. Verfasst von Sungjin Chung und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Chung, S., Lee, S. Y., Ryou, S., Hao, D. T. T., Koh, E. S., & Choi, B. (2026). Balcinrenone, a Nonsteroidal Mineralocorticoid Receptor Antagonist, Attenuates Renal Fibrosis Through Modulation of TGF-β-Smad Signaling. Journal of the American Society of Nephrology, 37(10S). https://doi.org/10.1681/asn.2026757drstb
Vancouver
Chung S, Lee SY, Ryou S, Hao DTT, Koh ES, Choi B. Balcinrenone, a Nonsteroidal Mineralocorticoid Receptor Antagonist, Attenuates Renal Fibrosis Through Modulation of TGF-β-Smad Signaling. Journal of the American Society of Nephrology. 2026;37(10S). doi:10.1681/asn.2026757drstb
BibTeX
@article{Chung2026,
author = {Chung, Sungjin and Lee, So Young and Ryou, Seyoung and Hao, Doan Thi Thien and Koh, Eun Sil and Choi, Bumsoon},
title = {Balcinrenone, a Nonsteroidal Mineralocorticoid Receptor Antagonist, Attenuates Renal Fibrosis Through Modulation of TGF-β-Smad Signaling},
journal = {Journal of the American Society of Nephrology},
year = {2026},
volume = {37},
number = {10S},
doi = {10.1681/asn.2026757drstb}
}
EUVIMED